Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaption

MLA

Shyama U. Tetar, et al. “Magnetic Resonance Imaging-Guided Radiotherapy for Intermediate- and High-Risk Prostate Cancer: Trade-off between Planning Target Volume Margin and Online Plan Adaption.” Physics and Imaging in Radiation Oncology, vol. 23, no. 92–96, July 2022, pp. 92–96. EBSCOhost, https://doi.org/10.1016/j.phro.2022.06.013.

APA

Shyama U. Tetar, Anna M.E. Bruynzeel, Lisa Verweij, Omar Bohoudi, Berend J. Slotman, Tezontl Rosario, Miguel A. Palacios, & Frank J. Lagerwaard. (2022). Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaption. Physics and Imaging in Radiation Oncology, 23(92–96), 92–96. https://doi.org/10.1016/j.phro.2022.06.013

Chicago

Shyama U. Tetar, Anna M.E. Bruynzeel, Lisa Verweij, Omar Bohoudi, Berend J. Slotman, Tezontl Rosario, Miguel A. Palacios, and Frank J. Lagerwaard. 2022. “Magnetic Resonance Imaging-Guided Radiotherapy for Intermediate- and High-Risk Prostate Cancer: Trade-off between Planning Target Volume Margin and Online Plan Adaption.” Physics and Imaging in Radiation Oncology 23 (92–96): 92–96. doi:10.1016/j.phro.2022.06.013.